NYSE:BSXMedical Equipment
A Look At Boston Scientific (BSX) Valuation As Electrophysiology Concerns Follow Strong Q4 Earnings
Boston Scientific (BSX) is back in focus after Q4 2025 adjusted earnings came in above consensus. However, investor attention has shifted to signs of stagnation in the company’s U.S. electrophysiology business.
See our latest analysis for Boston Scientific.
The share price has retreated sharply in recent months, with a 30 day share price return of 15.15% and a 90 day share price return of 24.68%, even though the 3 year total shareholder return sits at 60.57% and the 5 year total shareholder...